Metoprolol tartrate and Hypertrophy - a phase IV clinical study of FDA data

Summary:

Hypertrophy is reported as a side effect among people who take Metoprolol tartrate (metoprolol tartrate), especially for people who are female, 30-39 old, also take Lasix, and have Breast cancer.

The phase IV clinical study analyzes which people have Hypertrophy when taking Metoprolol tartrate. It is created by eHealthMe based on reports of 83,460 people who have side effects when taking Metoprolol tartrate from the FDA, and is updated regularly.

What is Metoprolol tartrate?

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 89,747 Metoprolol tartrate users. Check the latest studies of Metoprolol tartrate.

What is Hypertrophy?

Hypertrophy (increase in the volume of an organ or tissue due to the enlargement of its component cells) is found to be associated with 239 drugs and 292 conditions by eHealthMe. Check the latest studies of Hypertrophy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

83,460 people reported to have side effects when taking Metoprolol tartrate.
Among them, 11 people (0.01%) have Hypertrophy.

Could Metoprolol tartrate cause Hypertrophy?

Among these 11 people:

What is the gender of people who have Hypertrophy when taking Metoprolol tartrate? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Hypertrophy when taking Metoprolol tartrate? *

What are other drugs people take besides Metoprolol tartrate? *

What are other side effects people have besides Hypertrophy? *

Oedema Peripheral (superficial swelling): 7 people, 63.64%
Fatigue (feeling of tiredness): 6 people, 54.55%
Dyspnea (difficult or laboured breathing): 6 people, 54.55%
Depression: 5 people, 45.45%
Stress And Anxiety: 5 people, 45.45%
Blood Glucose Increased: 5 people, 45.45%
Blood Calcium Decreased: 5 people, 45.45%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 45.45%
Back Pain: 5 people, 45.45%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 5 people, 45.45%

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 9.09%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 9.09%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 9.09%
Breast Cancer: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol tartrate and have Hypertrophy?

- Check whether Hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metoprolol tartrate:

Metoprolol tartrate (89,747 reports)

Hypertrophy treatments and more:

Hypertrophy (835 reports)

Browse all side effects of Metoprolol tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertrophy:

Hypertrophy (239 drugs)

Browse all the conditions that are associated with Hypertrophy:

Hypertrophy (292 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Metoprolol tartrate) and Metoprolol tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.